Pfizer (PFE) volatility flat at 23 into positive blood thinner clinical results
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Join SI Premium – FREE
Pfizer (NYSE: PFE) is recently up 3.9% in pre-open trading following promising clinical results from stroke-preventing Eliquis. Deutsche Bank reiterated their Buy rating on PFE. Overall option implied volatility of 23 is near its six-month average according to Track Data.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) call put ratio 1.3 calls to 1 put into quarter results
- Winnebago Industries (WGO) September 32.50 calls active
- CrowdStrike Holdings Inc. (CRWD) call put ratio 1 call to 1 put into quarter results
Create E-mail Alert Related Categories
OptionsRelated Entities
Deutsche Bank, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
